Modern concepts of primary prevention;Neue konzepte der primärprävention erfordern umdenken

Medizinische Klinik

Volumn 96, Issue 5, 2001, Pages 261-269

  Schmermund, Alex ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Atherosclerosis; Coronary artery disease; Imaging; Prevention

Indexed keywords

CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HUMAN; MORTALITY; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; SURVIVAL;

EID: 0342538722     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00002203     Document Type: Review

References (69)

1. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996;93:1951-3.
2. Arad Y, Spadaro LA, Goodman K, et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000;36:1253-60.
3. Assmann G, Sculte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged me. Am J Cardiol 1996;77:1179-84.
4. Assmann G, Carmena R, Cullen P, et al., for the International Task Force tor the Prevention of Coronary Heart Disease. Coronary heart disease: reducing the risk. The scientific background for primary and secondary prevention of coronary heart disease. A worldwide view. Nutr Metab Cardiovasc Dis 1998;8:205-71.
5. Bethesda Conference Report. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary heart disease events. J Am Coll Cardiol 1996;27:957-1047.
6. Callister TQ, Cooil B, Raya SP, et al. Coronary artery disease: improved reproducibility of calcium screening with an electron-beam CT volumetric method. Radiology 1998;208:807-14.
7. Callister TQ, Raggi P, Cooil B, et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998;339:1972-8.
8. Carlsson CM, Carnes M, McBride PE, et al. Managing dyslipidemia in older adults. J Am Geriatr Soc 1999; 47:1458-65.
9. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-96.
10. Chambless L, Keil U, Dobson A, et al. Population versus clinical view of case fatality from acute coronary heart disease - results from the WHO Monica project 1985-1990. Circulation 1997;96:3849-59.
11. Cole CR, Blackstone EH, Pashkow FJ, et al. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999;341:1351-7.
12. Cremer P, Nagel P, Labrot B, et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Goettingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994;24:444-53.
13. Cremer P, Nagel D, Mann H, et al. Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. Atherosclerosis 1997;129:221-30.
14. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;3226:381-6.
15. Cullen P, von Eckardstein A, Assmann G. Diagnosis and management of new cardiovascular risk factors. Eur Heart J 1998;19:Suppl O:O13-9.
16. Detrano RC, Wong ND, Doherty TM, et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 1999; 99:2633-8.
17. Devereux R, Alderman M. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development ot morbid events. Circulation 1993; 88:1444-55.
18. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association: The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulanon 1999;100:1132-3.
19. Domanski MJ, Davis BR, Pfeffer MA, et al. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension 1999;34:375-80.
20. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;279:1615-22.
21. Emond M, Mock MB, Davis KB, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994; 90:2645-57.
22. Erbel R, Möhlenkamp S, Schmermund A. Elektronenstrahltomographie: Schlussbemerkung. Dtsch Ärztebl 1998;95:A-2853-4.
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. National Cholesterol Education Program: second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1329-445.
24. Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102:506-10,
25. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260-315.
26. Girelli D, Russo C, Ferraresi P, et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000;343:774-80.
27. Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Noninvasive tests of atherosclerotic burden. Writing Group III. Circulation 2000;101:e16-22.
28. Grundy SM, Wilhelmsen L, Rose R, et al. Coronary heart disease in high-risk populations: lessons from Finland. Eur Heart J 1990;11:462-71.
29. Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham. A statement for healthcare professionals from the AHA Task Force on Risk Reduction. Circulation 1998;97:1876-87.
30. Grundy SM. Age as a risk factor: you are as old as your arteries. Am J Cardiol 1999;83:1455-7.
31. Grundy SM. Primary prevention ot coronary heart disease. Integrating risk assessment with intervention. Circulation 1999;100:988-98.
32. Grundy SM, Bazzarre T, Cleeman J, et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Medical office assessment. Writing Group I. Circulation 2000; 101:e3-11.
33. Hackett D, Davies G, Maseri A. Preexisting coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J 1988;9:1317-23.
34. Haffner SM, Lehte S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:313-8.
35. Khoury Z, Schwartz R, Gottlieb S, et al. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 1997;80:1429-33.
36. Koenig W, Sund M, Froelich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-42.
37. Kuller LH. Discussion: Why measure atherosclerosis? AHA symposium/epidemiology meeting: atherosclerosis. Circulation 1993;87:Suppl II:II-34-7.
38. LaRosa JC. Cholesterol agonistics. Ann Intern Med 1996;124:505-8.
39. Little WC. Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-66.
40. Lloyd-Jones DM, Larson MG, Beiser A, et al. Lifetime risk of developing coronary artery disease. Lancet 1999;353:89-92.
41. Löwel H, Engel S, Hormann A, et al. Akuter Herzinfarkt und plötzlicher Herztod aus epidemiologischer Sicht. Intensivmedizin 1999;36:652-61.
42. Newman AB, Sutton-Tyrrell K, Vogt MT, et al. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993;270:487-9.
43. O'Leary DH, Polak JF, Kronmal RA, et al., for the Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22.
44. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes: report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association. Circulation 1993;88:819-28.
45. O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis ot coronary artery disease. J Am Coll Cardiol. 2000;36: 326-40.
46. Pitt B, Rubenfire M. Risk Stratification for the detection of preclinical coronary artery disease. Circulation 1999; 99:2610-2.
47. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000;101:850-5.
48. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-86.
49. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
50. Roger VL, Jacobsen SJ, Pellikka PA, et al. Prognostic value of treadmill exercise testing. A population-based study in Olmsted County, Minnesota. Circulation 1998;98:2836-41.
51. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
52. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:114-26.
53. Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995; 92:2157-62.
54. Schmermund A, Denktas AE, Rumberger JA, et al. Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease: comparison with cardiac risk factors and radionuclide perfusion imaging. J Am Coll Cardiol 1999;34:777-86.
55. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results ot the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
56. Shepherd J, Cobbe SM, Ford I, et al., for the West of Scotland Coronary Prevention Study Group. Prevention of coronary artery disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333:1301-7.
57. Shepherd J. From best evidence to best practice - what are the obstacles? Atherosclerosis 1999;147:Suppl 1:S45-51.
58. Shinnar M, Fallon JT, Wherli S, et al. The diagnostic accuracy of ex-vivo MRI for human atherosclerotic plaque characterization. Arterioscl Thromb Vasc Biol 1999;19:2756-61.
59. Smith SC, Amsterdam E, Balady, et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Tests for silent and inducible ischemia. Writing Group II. Circulation 2000;101:e12-5.
60. Smith SC, Greenland P, Grundy SM. Prevention Conference V. Beyond secondary prevention: Identifying the high-risk patient for primary prevention. Executive summary. Circulation 2000;101:111-6.
61. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison ot placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-64.
62. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk ot premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256:2823-8.
63. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. Findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-8.
64. Statistisches Bundesamt. Datenreport 1999. Zahlen und Fakten über die Bundesrepublik Deutschland. Teil 1, Abschnitt 8 (Gesundheir). Wiesbaden, 1999:176-95.
65. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [Erratum veröffentlicht in Arch Intern Med 1998;158:573]. Arch Intern Med 1997; 157:2413-46.
66. Ulrich S, Hingorani AD, Martin J, et al. What is the optimal age for starting lipid lowering treatment? A mathematical model. Br Med J 2000;320:1134-40.
67. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Circulation 1996;94:1175-92.
68. Wilson PWF, D'Agostino RB, Levy D. et al. Prediction ot coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
69. Wood D, De Backer G, Faergeman O, et al. Prevention of coronary heart disease in clinical practice. Recommendations ot the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998;19:1434-503.